Pharma Rewires Drug Development With AI Operations
Drug development has grown too expensive and too slow to rely on manual workflows, as the cost of bringing a single therapy to market climbs into the billions and approval timelines stretch across a decade or more. In response, pharmaceutical companies are reshaping their operating models around artificial intelligence (AI). By embedding machine learning […]
Читать дальше...